128 related articles for article (PubMed ID: 2999734)
1. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
Janicka G; Chyczewska E; Przylipiak M; Kowal E
Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
[No Abstract] [Full Text] [Related]
2. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
3. [Immunological status in small cell and squamous cell lung cancer].
Janicka G; Przylipiak M; Chyczewska E; Kowal E
Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
[No Abstract] [Full Text] [Related]
4. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
5. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
6. [Evaluation of cellular immunity in pulmonary sarcoidosis and primary lung cancer].
Li JP
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):100-2, 128. PubMed ID: 1327551
[TBL] [Abstract][Full Text] [Related]
7. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
8. [Pathological variability and cancer treatment in lung cancer].
Kodama T
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
[TBL] [Abstract][Full Text] [Related]
9. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
10. [Characteristics of the growth rate of small-cell lung cancer].
Korman DB
Vopr Onkol; 1989; 35(2):158-63. PubMed ID: 2538958
[TBL] [Abstract][Full Text] [Related]
11. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer: current evaluation and therapy.
Vosika G
Minn Med; 1979 Jul; 62(7):519-21. PubMed ID: 226856
[No Abstract] [Full Text] [Related]
13. Lung cancer.
Hansen HH; Rørth M
Cancer Chemother Biol Response Modif; 1990; 11():432-52. PubMed ID: 2171611
[No Abstract] [Full Text] [Related]
14. [The natural history of lung cancer].
Miyamoto H; Kawakami Y
Kokyu To Junkan; 1988 Sep; 36(9):961-7. PubMed ID: 2853436
[No Abstract] [Full Text] [Related]
15. [Treatment of bronchial carcinoma].
Tofte T
Tidsskr Nor Laegeforen; 1973 Nov; 93(33):2416-8. PubMed ID: 4359844
[No Abstract] [Full Text] [Related]
16. Immunologic aspects of small cell carcinoma.
Forbes JT; Greco FA; Oldham RK
Semin Oncol; 1978 Sep; 5(3):263-71. PubMed ID: 80823
[No Abstract] [Full Text] [Related]
17. Lung cancer: progress in diagnosis and treatment.
Carney DN
Ir Med J; 1984 Oct; 77(10):327-9. PubMed ID: 6094392
[No Abstract] [Full Text] [Related]
18. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic aspects of bronchopulmonary carcinoma].
Dammacco F; Vacca A
Arch Monaldi Mal Torace; 1991; 46(1-6):59-71. PubMed ID: 1669001
[No Abstract] [Full Text] [Related]
20. [Diagnostic value of the tuberculin skin test as a parameter of cellular immunocompetence in cancer patients].
Sone S; Ogushi F; Tsubura H; Fukuoka M
Kekkaku; 1983 Oct; 58(10):559-62. PubMed ID: 6319794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
